On July 18, 2018 Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, reported that it will release its financial results for the second quarter ended June 30, 2018, after the close of the financial markets on Monday, July 30, 2018 (Press release, Alimera Sciences, JUL 18, 2018, View Source [SID1234527772]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results. The call will be held at 9:00 AM ET, on Tuesday, July 31, 2018. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Details

Conference date: Tuesday July 31, 2018 9:00 AM ET

Conference dial-in: 877.269.7756

International dial-in: 201.689.7817

Conference Call Name: Alimera Sciences Second Quarter 2018 Results Call